Q3 Sales Up 5% to $779M, Adjusted EBITDA Jumps $21M to $51M
TSEOQ has more than doubled off its 52-week low of $0.001.
Summary
Trinseo posted Q3 net sales of $779M, up 5% year over year, with adjusted EBITDA of $51M, a $21M improvement. The sales gain came from higher prices, not volume — two segments saw lower volumes on weak demand and pulled-forward purchases. Net loss narrowed to $49M, an improvement of $61M, but $56M of that came from lower interest expense tied to the automatic stay in the debt restructuring proceedings rather than operations. Free cash flow was $15M while restructuring professional fees ran about $50M, so the fees exceeded reported free cash flow — a real liquidity squeeze. Operating cash flow of $26M against $11M capex kept cash generation positive, but the restructuring remains the dominant story for this sub-penny OTC equity.
At the time of this announcement, TSEOQ was trading at $0.00 on OTC in the Manufacturing sector, with a market capitalization of approximately $128K. The 52-week trading range was $0.00 to $0.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.